An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
Completed
Abbott
Phase 3
2003-03-01
The purpose of this study is to determine the safety and effectiveness of Depakote ER
(Divalproex Sodium Extended-Release Tablets) compared to placebo in the treatment of bipolar
disorder, manic or mixed type in children and adolescents ages 10-17 years.
Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder
Completed
Eli Lilly and Company
Phase 4
2004-10-01
The goals of this study are:
A. To determine whether olanzapine can help patients with bipolar disorder who currently have
mild to moderate mania.
B. To assess the safety of olanzapine and any side effects that might be associated with it,
as well as the quality of life and functioning of patients treated with olanzapine.
C. To assess how olanzapine compares to divalproex.
Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
Completed
VA Office of Research and Development
Phase 3
2003-10-01
The purposes of this study are:
- To study the efficacy of divalproex in the treatment of PTSD;
- To study the plasma GABA (gamma aminobutyric acid) levels before and after treatment
with divalproex in PTSD.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
